Quest Diagnostics and Waters will expand at-home HPV screening in 2027, offering extended genotyping via the Onclarity ...

Waters WAT recently announced a partnership with Labcorp Holdings Inc. LH to expand access to the FDA-approved BD Onclarity ...

Testing for high-risk human papillomaviruses every five years – even with a self-collected sample – is the “preferred screening strategy” for cervical cancer starting at age 30, according to a new ...

Newswise — Decades ago, cervical cancer was considered one of the deadliest types of cancer among women in the U.S., according to the Centers for Disease Control and Prevention (CDC). Today, the ...

Bottom Line: The risk of detecting cervical precancer eight years after a negative human papillomavirus (HPV) screening was found to be similar to the risk after three years (the commonly recommended ...

Researchers have developed a simple, affordable human papillomavirus test that delivers results in less than an hour with no specialized laboratory required. The breakthrough could provide an option ...

Please provide your email address to receive an email when new articles are posted on . Recent findings suggest that with HPV tests, intervals between cervical screenings can be extended to 5 years ...

Cervical cancer is preventable through vaccination for human papillomavirus (HPV) and treatable through early detection. But the National Cancer Institute (NCI) reports more than half of all cervical ...

Research has increasingly shown that HPV testing is more effective than cytology at detecting cervical precancer. A cohort study showed that patients who tested HPV negative had the lowest cumulative ...

A prospective cohort study in Papua New Guinea found that restricting HPV DNA testing to eight high-risk types, with or ...